<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="of those receiving ARV treatment in Brazil will be using" exact="efavirenz" post="by the end of 2007. Efavirenz (in tablets of"/>
 <result pre="Brazil will be using efavirenz by the end of 2007." exact="Efavirenz" post="(in tablets of 600 mg) was sold in Brazil"/>
 <result pre="threatened Merck with a compulsory license unless Brazil could sell" exact="efavirenz" post="at a rate equal to or less than the"/>
 <result pre="[18, 19], the Thai government issued a compulsory license for" exact="efavirenz" post="on December 6, 2006, and began the local production"/>
 <result pre="2006, the Thai government was actively negotiating the price of" exact="Kaletra" post="with Abbott. In 2006, Abbott initially offered a rate"/>
 <result pre="nationwide anthrax scare in USA resulting in rising demands for" exact="ciprofloxacin" post="(Cipro). Anecdotally, many health professionals believe that &quot;it is"/>
 <result pre="for large pharmaceutical companies. Therefore, issuing a compulsory license for" exact="Cipro" post="was a controversial act. In the end, the US"/>
 <result pre="cost of the ARV drugs. For instance, the price of" exact="lamivudine" post="(3TC) could be reduced to one-tenth of the current"/>
 <result pre="reduced to one-tenth of the current price in China and" exact="nevirapine" post="to one-tenth of its international price. Trizivir would only"/>
 <result pre="Reddy, an Indian pharmaceutical company, started by producing API for" exact="Ibuprofen" post="and exporting API of Methyldopa to Germany in 1986."/>
 <result pre="started by producing API for Ibuprofen and exporting API of" exact="Methyldopa" post="to Germany in 1986. Its API production passed SFDA"/>
 <result pre="the US government forcing Bayer to reduce the price of" exact="Cipro" post="using the compulsory licensing as a last resort after"/>
</results>
